5:33 PM
 | 
Sep 13, 2017
 |  BC Extra  |  Politics & Policy

California Senate passes drug pricing transparency bill

On Wednesday, the California Senate passed by a vote of 31-8 Senate Bill 17, which would require drug makers to disclose and justify prescription drug price increases.

The bill would require a manufacturer of a prescription drug with a wholesale acquisition cost (WAC) of more than $40 for a course of therapy to notify purchasers 60 days prior to an increase of over 16% in a two-year period. Manufacturers would also...

Read the full 337 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >